methotrexate has been researched along with Purpura, Thrombotic Thrombocytopenic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aubin, F; Badie, J; Deconinck, E; Faller, JP; Krattinger, É; Philippe, L | 1 |
| Atkinson, K; Biggs, JC; Concannon, AJ; Dodds, AJ; Hayes, J; Naidoo, D; Ralston, M | 1 |
| Landaw, EM; Paquette, RL; Tran, L | 1 |
3 other study(ies) available for methotrexate and Purpura, Thrombotic Thrombocytopenic
| Article | Year |
|---|---|
Fatal thrombotic thrombocytopenic purpura in a psoriasis patient treated with ustekinumab and methotrexate.
Topics: Adult; Dermatologic Agents; Fatal Outcome; Humans; Immunosuppressive Agents; Male; Methotrexate; Multiple Organ Failure; Psoriasis; Purpura, Thrombotic Thrombocytopenic; Ustekinumab | 2015 |
Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes.
Topics: Acute Kidney Injury; Anemia, Aplastic; Bilirubin; Bone Marrow Transplantation; Creatinine; Cyclosporins; Humans; Kidney Diseases; Leukemia; Methotrexate; Purpura, Thrombotic Thrombocytopenic; Syndrome; Time Factors; Uremia | 1983 |
Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Glucocorticoids; Graft vs Host Disease; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Retrospective Studies; Risk Factors; Transplantation Conditioning; Treatment Outcome | 1998 |